MANAGEMENT STRATEGIES IN TERM PROM AND ITS IMPACT ON FETOMATERNAL OUTCOMES
DOI:
https://doi.org/10.71000/wyarf079Keywords:
Birth Asphyxia, Apgar Score, Cesarean Section, Induced Labor, Maternal Infection, Premature Rupture of Fetal Membranes, Term PregnancyAbstract
Background: Premature rupture of membranes (PROM) at term, defined as rupture of fetal membranes before labor onset at or beyond 37 weeks of gestation, is a common obstetric event affecting approximately 8–10% of pregnancies. It poses a clinical dilemma due to its association with maternal infections such as chorioamnionitis and neonatal complications including sepsis and birth asphyxia. The decision between conservative and active management can significantly influence maternal and neonatal outcomes.
Objective: To compare the maternal and neonatal outcomes of conservative versus active management in women with the term PROM, focusing on cesarean section rates, neonatal hyperbilirubinemia, and birth asphyxia.
Methods: This prospective randomized controlled trial was conducted on 138 pregnant women with singleton-term pregnancies diagnosed with PROM. Participants were randomly allocated into two equal groups: Group A (n = 69) received conservative management with close observation, antibiotics, and supportive care, while Group B (n = 69) underwent active management involving labor induction within six hours using prostaglandin E2 and oxytocin. Primary outcomes included cesarean section rate, neonatal hyperbilirubinemia (serum bilirubin >5 mg/dL), and birth asphyxia (Apgar score <5 at 1 minute). Secondary outcomes assessed included latency period, maternal infection, and postpartum hemorrhage.
Results: The cesarean section rate was 8.13% in Group A and 17.44% in Group B. Neonatal hyperbilirubinemia occurred in 13.37% of Group A and 21.51% of Group B. Birth asphyxia was recorded in 9.88% of Group A and 25.58% of Group B. Group A had a longer latency period (17.8 ± 4.2 hours) compared to Group B (9.3 ± 3.6 hours), with no significant increase in maternal infection.
Conclusion: Conservative management of the term PROM was associated with better neonatal outcomes and lower cesarean rates, indicating its suitability in selected low-risk patients under close monitoring.
References
Bennett PR, Brown RG, MacIntyre DA. Vaginal Microbiome in Preterm Rupture of Membranes. Obstet Gynecol Clin North Am. 2020;47(4):503-21.
Lin D, Hu B, Xiu Y, Ji R, Zeng H, Chen H, et al. Risk factors for premature rupture of membranes in pregnant women: a systematic review and meta-analysis. BMJ Open. 2024;14(3):e077727.
Lee WL, Chang WH, Wang PH. Risk factors associated with preterm premature rupture of membranes (PPROM). Taiwan J Obstet Gynecol. 2021;60(5):805-6.
Deprest JA, Benachi A, Gratacos E, Nicolaides KH, Berg C, Persico N, et al. Randomized Trial of Fetal Surgery for Moderate Left Diaphragmatic Hernia. N Engl J Med. 2021;385(2):119-29.
Humberg A, Fortmann I, Siller B, Kopp MV, Herting E, Göpel W, et al. Preterm birth and sustained inflammation: consequences for the neonate. Semin Immunopathol. 2020;42(4):451-68.
Gatta LA, Hughes BL. Premature Rupture of Membranes with Concurrent Viral Infection. Obstet Gynecol Clin North Am. 2020;47(4):605-23.
Gorczyca K, Kozioł MM, Kimber-Trojnar Ż, Kępa J, Satora M, Rekowska AK, et al. Premature rupture of membranes and changes in the vaginal microbiome - Probiotics. Reprod Biol. 2024;24(3):100899.
Gibson KS, Brackney K. Periviable Premature Rupture of Membranes. Obstet Gynecol Clin North Am. 2020;47(4):633-51.
Sorrenti S, Di Mascio D, Khalil A, D'Antonio F, Rizzo G, Zullo F, et al. Outcome of prelabor rupture of membranes before or at the limit of viability: systematic review and meta-analysis. Am J Obstet Gynecol MFM. 2024;6(6):101370.
Zhang Z, Mei L, Li L, Xiao J, Wu X, Yuan Y. Maternal and neonatal outcomes of twin pregnancies complicated by gestational diabetes mellitus. Endocrine. 2024;84(2):388-98.
Freeman SW, Denoble A, Kuller JA, Ellestad S, Dotters-Katz S. Management of Preterm Premature Rupture of Membranes in the Late Preterm Period. Obstet Gynecol Surv. 2022;77(5):283-92.
Conde-Agudelo A, Romero R, Jung EJ, Garcia Sánchez Á J. Management of clinical chorioamnionitis: an evidence-based approach. Am J Obstet Gynecol. 2020;223(6):848-69.
Ronzoni S, Boucoiran I, Yudin MH, Coolen J, Pylypjuk C, Melamed N, et al. Guideline No. 430: Diagnosis and management of preterm prelabour rupture of membranes. J Obstet Gynaecol Can. 2022;44(11):1193-208.e1.
Evaluating Progestogens for Preventing Preterm Birth International Collaborative (EPPPIC): meta-analysis of individual participant data from randomised controlled trials. Lancet. 2021;397(10280):1183-94.
Lin LL, Hung JN, Shiu SI, Su YH, Chen WC, Tseng JJ. Efficacy of prophylactic antibiotics for preterm premature rupture of membranes: a systematic review and network meta-analysis. Am J Obstet Gynecol MFM. 2023;5(7):100978.
Jung E, Romero R, Suksai M, Gotsch F, Chaemsaithong P, Erez O, et al. Clinical chorioamnionitis at term: definition, pathogenesis, microbiology, diagnosis, and treatment. Am J Obstet Gynecol. 2024;230(3s):S807-s40.
Beck C, Gallagher K, Taylor LA, Goldstein JA, Mithal LB, Gernand AD. Chorioamnionitis and Risk for Maternal and Neonatal Sepsis: A Systematic Review and Meta-analysis. Obstet Gynecol. 2021;137(6):1007-22.
Jain VG, Willis KA, Jobe A, Ambalavanan N. Chorioamnionitis and neonatal outcomes. Pediatr Res. 2022;91(2):289-96.
Feduniw S, Pruc M, Ciebiera M, Zeber-Lubecka N, Massalska D, Zgliczynska M, et al. Biomarkers for Pregnancy Latency Prediction after Preterm Premature Rupture of Membranes-A Systematic Review. Int J Mol Sci. 2023;24(9).
Aliabadi T, Saberi EA, Motameni Tabatabaei A, Tahmasebi E. Antibiotic use in endodontic treatment during pregnancy: A narrative review. Eur J Transl Myol. 2022;32(4).
Lorthe E, Letouzey M, Torchin H, Foix L'Helias L, Gras-Le Guen C, Benhammou V, et al. Antibiotic prophylaxis in preterm premature rupture of membranes at 24-31 weeks' gestation: Perinatal and 2-year outcomes in the EPIPAGE-2 cohort. Bjog. 2022;129(9):1560-73.
McGoldrick E, Stewart F, Parker R, Dalziel SR. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev. 2020;12(12):Cd004454.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Ikram Ullah, Rehana Bhittani, Iftikhar alam, Asma Zubair , Aisha, Shahinda (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
